SYDNEY DOWELL: Open Payments
NPI 1144243379 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 50 payments from 14 companies in 2025. Trend: 2023 $814 · 2024 $1,063 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $250 |
| PFIZER INC. | 17 | $209 |
| Exact Sciences Corporation | 3 | $50 |
| Novo Nordisk Inc | 1 | $48 |
| Astellas Pharma US Inc | 2 | $47 |
| Corcept Therapeutics | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Medtronic, Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
Products named: VRAYLAR, NURTEC ODT, Wegovy, Veozah, Korlym, TRELEGY ELLIPTA, Cologuard Collection Kit, ELIQUIS.
Industry payments across KY — which companies pay providers there.
